Nanite, Inc.
PrivateLast Round
Grant
May 8, 2024
Total Funding Raised
$11.9M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Nanite, Inc. is a biotechnology company that develops programmable polymer nanoparticles for non-viral gene delivery using an AI-driven platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Medical AI, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanite, Inc. Comparables
Compare Nanite, Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Envoya | 86% | |
| Liberate Bio | 83% | |
| Hopewell Therapeutics | 83% |
Nanite, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | May 8, 2024 | ||||
| Grant | Jan 1, 2024 | ||||
| Grant | Aug 10, 2023 | ||||
| Grant | Mar 15, 2023 | ||||
| Seed | Feb 15, 2023 |
Key People
Founding team and executive leadership
Nanite, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Zetta Venture Partners | Seed |
| Gates Foundation | Grant |
| The Bill & Melinda Gates Foundation Trust | Grant |
| Cystic Fibrosis Foundation | Grant |
| Arkitekt Ventures | Seed |
| National Heart, Lung, and Blood Institute | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 20, 2026
Monthly visitors increased 58% MoM.
- Jul 25, 2026
Monthly visitors grew 2930% MoM, from 50 to 1.5K.
Nanite, Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nanite, Inc.'s valuation, stock price, and market status.
Is Nanite, Inc. a public or private company?
Nanite, Inc. is a private company.
What is the current stock price of Nanite, Inc.?
Nanite, Inc. is a private company with no public stock price. No recent secondary market data is available.
How much is Nanite, Inc. worth (valuation)?
Valuation information for Nanite, Inc. is not publicly available.
Can I buy Nanite, Inc. stock?
Nanite, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Nanite, Inc.'s last funding round?
Nanite, Inc.'s most recent funding round was Grant on January 1, 2024.
Who are the main investors in Nanite, Inc.?
Key investors in Nanite, Inc. include Zetta Venture Partners, Cystic Fibrosis Foundation, National Heart, Lung, and Blood Institute.
Will Nanite, Inc. IPO soon?
No public IPO plans have been announced for Nanite, Inc..
How can I track Nanite, Inc. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nanite, Inc.'s secondary market activity and sign up for updates.